Thompson Siegel & Walmsley’s TriSalus Life Sciences TLSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.28M Sell
529,534
-7,000
-1% -$33.2K 0.04% 288
2026
Q2
$2.44M Sell
536,534
-47,040
-8% -$187K 0.04% 286
2026
Q1
$2.33M Buy
+583,574
New +$2.86M 0.04% 275

Other funds holding TLSI

Thompson Siegel & Walmsley's TLSI Position: Q3 2026 in Review

Thompson Siegel & Walmsley reduced its TriSalus Life Sciences (TLSI) stake by 1.3% in Q3 2026, selling an estimated $33.2K and leaving 529,534 shares worth $2.28M. The position accounts for 0.04% of the portfolio, ranked #288.

Thompson Siegel & Walmsley first reported a position in TLSI in Q1 2026 and has held it in 3 quarters since. The position peaked at $2.44M in Q2 2026. 82 funds tracked by Wall St. Rank hold TLSI as of Q3 2026.

  • Thompson Siegel & Walmsley held 529,534 shares of TriSalus Life Sciences worth $2.28M as of Q3 2026.
  • Thompson Siegel & Walmsley sold 7,000 TriSalus Life Sciences shares in Q3 2026, an estimated $33.2K.
  • TriSalus Life Sciences made up 0.04% of Thompson Siegel & Walmsley's portfolio in Q3 2026, its #288 holding.
  • Thompson Siegel & Walmsley first reported a position in TriSalus Life Sciences in Q1 2026 and has held it in 3 quarters since.
  • Thompson Siegel & Walmsley's TriSalus Life Sciences position peaked at $2.44M in Q2 2026.
  • 82 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q3 2026.

Based on Thompson Siegel & Walmsley's 13F filing for Q3 2026, filed 5 Nov 2026.